Education Services

Apollo Group Revenues $1.05B Vs. $1.03B Consensus (NASDAQ: APOL)

Apollo Group, Inc. (NASDAQ: APOL) today reported financial results for the three months ended February 28, 2011. Consolidated net revenue for the second quarter of fiscal 2011 totaled $1,048.6 million, which represents a 2.0% decrease from the second quarter of fiscal 2010. The Company reported...

US stock futures are higher this morning, as investors are awaiting data on home prices and consumer confidence. Futures on the Dow Jones Industrial Average gained 24 points to 12,138.00 and S&P 500 index futures climbed 2.70 points to 1,304.90. Nasdaq 100 futures rose 6.75 points to 2,302.50...

Apollo Group Inc (NASDAQ: APOL) is expected to report its FQ2 EPS at $0.69 on revenue of $1.03 billion. Landec Corporation (NASDAQ: LNDC) is projected to post its Q3 earnings at $0.07 per share on revenue of $66.75 million. McCormick & Company Incorporated (NYSE: MKC) is expected to report...

Some of the stocks that may grab investor focus today are: Wall Street expects McCormick & Company Incorporated (NYSE: MKC) to report its Q1 EPS at $0.54 on revenue of $802.91 million. MKC shares closed at $49.61 yesterday. Lennar Corporation (NYSE: LEN) is estimated to post a Q1 loss at $0....

CNBC Options Action's Mike Khouw said on the show that Apollo Group, Inc. (NASDAQ: APOL) has been under a lot of pressure recently. The media coverage hasn't been that good, and there are some regulatory concerns for the sector. He also said that after a big sell off, this stock started to show...

In a Form 4 filed earlier today, Chinacast Education Corp. (NASDAQ: CAST) Director, Ned Sherwood, reported that he bought 358,561 shares of CAST on March 24th for an average price of $6.50. The transaction totaled $2,331,077. Ned Sherwood owns 2,847,324 indirect shares of CAST. Source: The...

Point Roberts, WA. March 25, 2011 � Investorideas.com, a leader in sector research including biotech and biodefense stocks, presents an interview with Jim Joyce, CEO of Aethlon Medical (OTCBB: AEMD). InvestorIdeas: What opportunities exist for small organizations that want to participate in the...

Shares of Apollo Group, Inc. (NASDAQ: APOL) are higher on the session by 2.43%, trading at $43.35. Overall call volume is now running at 2.37x the daily average, with 67% of all calls traded being purchases on the offer. 4,289 contracts have traded on the session so far. Apollo Group, Inc. is a...

Deutsche Bank Reports On Upcoming Gainful Employment Rule (APOL) Deutsche Bank has reported that the Department of Education's Gainful Employment rule will be released in the coming weeks. According to Deutsche Bank, "The Dept. of Education's (DoE) final Gainful Employment (GE) rule is expected...

Citigroup has raised the price target on DeVry Inc. (NYSE: DV) from $57 to $64 and maintains its Buy rating.

Roth Capital Downs REVU To Neutral Analysts at Roth Capital downgrade Princeton Review Inc (NASDAQ: REVU) from “buy” to “neutral.” REVU shares dropped 2.91% to close at $0.400 yesterday. More Analyst Ratings here

Cusick's Corner Stocks rose earlier on the day after G7 central banks agreed to coordinate efforts in the currency markets to help weaken the Japanese yen. Japan continues to struggle with their crisis – however, there was not much focus on the news that Japan's nuclear alert level rose from 4 to...

Point Roberts, WA - March 18, 2011- Investorideas.com releases an industry snapshot on HIV- AIDS drug makers and recent data that suggests the HIV virus has developed drug resistance and that drug industry is not acting fast enough to get new drugs into the pipeline to combat the potential threats...

Point Roberts, WA - March 18, 2011 - Investorideas.com, a leader in investor sector research including biotech and pharma stocks releases a sector snapshot on the HIV- AIDS drug makers and recent data that suggests the HIV virus may be following the path of bacteria that has developed drug...